• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

toll-样受体及其下游分子在非酒精性脂肪性肝病发生发展中的作用。

Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease.

机构信息

Department of Gastroenterology and Neurology, Akita University Graduate School of Medicine, 1-1-1 Hondo Akita-shi, Akita 010-8543, Japan.

出版信息

Gastroenterol Res Pract. 2010;2010:362847. doi: 10.1155/2010/362847. Epub 2011 Jan 17.

DOI:10.1155/2010/362847
PMID:21274430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3026974/
Abstract

Activation of innate immunity is associated with the development of liver disease, including non-alcoholic fatty liver disease (NAFLD). In the innate immune system, Toll-like receptors (TLRs) are sensors that recognize bacterial and viral components such as lipopolysaccharide, bacterial DNA, and peptidoglycan. Recent data have demonstrated that the liver is exposed to a high load of TLR ligands due to bacterial overgrowth and increased intestinal permeability in NAFLD. Upon stimulation by these TLR ligands, hepatic immune cells produce various mediators that are involved in host defense. On the other hand, these mediators alter lipid metabolism, insulin signaling, and cell survival. Indeed, some TLR-deficient mice demonstrate lesser degrees of NAFLD even though TLR ligands are increased. This paper will highlight the recent progress on the study of TLR signaling and their downstream molecules in the development of NAFLD.

摘要

先天免疫的激活与肝脏疾病的发展有关,包括非酒精性脂肪性肝病(NAFLD)。在先天免疫系统中,Toll 样受体(TLR)是识别细菌和病毒成分(如脂多糖、细菌 DNA 和肽聚糖)的传感器。最近的数据表明,由于 NAFLD 中细菌过度生长和肠道通透性增加,肝脏暴露于大量 TLR 配体中。这些 TLR 配体刺激后,肝免疫细胞产生各种参与宿主防御的介质。另一方面,这些介质改变脂质代谢、胰岛素信号和细胞存活。事实上,一些 TLR 缺陷型小鼠即使 TLR 配体增加,其 NAFLD 的程度也较轻。本文将重点介绍 TLR 信号及其下游分子在 NAFLD 发展中的最新研究进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1272/3026974/450aac059530/GRP2010-362847.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1272/3026974/450aac059530/GRP2010-362847.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1272/3026974/450aac059530/GRP2010-362847.001.jpg

相似文献

1
Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. toll-样受体及其下游分子在非酒精性脂肪性肝病发生发展中的作用。
Gastroenterol Res Pract. 2010;2010:362847. doi: 10.1155/2010/362847. Epub 2011 Jan 17.
2
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.肠道微生物群和Toll样受体在非酒精性脂肪性肝病中的作用。
World J Gastroenterol. 2014 Jun 21;20(23):7381-91. doi: 10.3748/wjg.v20.i23.7381.
3
The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease.肠道微生物群和Toll样受体在肥胖症和非酒精性脂肪性肝病中的作用
J Obes Metab Syndr. 2017 Jun;26(2):86-96. doi: 10.7570/jomes.2017.26.2.86. Epub 2017 Jun 30.
4
Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的小肠细菌过度生长与Toll样受体信号传导
J Gastroenterol Hepatol. 2016 Jan;31(1):213-21. doi: 10.1111/jgh.13058.
5
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
6
Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者肝脏中 Toll 样受体 1-5 的表达升高,但 TLR 6-10 的表达不升高。
Liver Int. 2015 Feb;35(2):562-8. doi: 10.1111/liv.12442. Epub 2014 Jan 12.
7
FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.FBXW7 通过抑制 HMGB1 介导的固有免疫信号转导来减轻非酒精性脂肪性肝病小鼠模型的肝炎症和胰岛素抵抗。
Mol Med. 2019 Jun 18;25(1):29. doi: 10.1186/s10020-019-0099-9.
8
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease.Toll 样受体 1 可能成为非酒精性脂肪性肝病的治疗靶点。
Sci Rep. 2021 Sep 8;11(1):17815. doi: 10.1038/s41598-021-97346-9.
9
Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease.Toll 样受体与代谢(功能)障碍相关脂肪性肝病。
Pharmacol Res. 2022 Nov;185:106507. doi: 10.1016/j.phrs.2022.106507. Epub 2022 Oct 14.
10
Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy.模式识别受体在非酒精性脂肪性肝病的发生和向肝细胞癌进展中的作用:一种新兴的治疗策略。
Front Endocrinol (Lausanne). 2023 Mar 20;14:1145392. doi: 10.3389/fendo.2023.1145392. eCollection 2023.

引用本文的文献

1
Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases.细菌细胞外囊泡:肝病中肠-肝轴相互作用的新兴介质
Front Cell Infect Microbiol. 2025 Jun 20;15:1620829. doi: 10.3389/fcimb.2025.1620829. eCollection 2025.
2
Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications.健康与疾病中的巨噬细胞信号通路:从实验室到临床应用
MedComm (2020). 2025 Jun 16;6(7):e70256. doi: 10.1002/mco2.70256. eCollection 2025 Jul.
3
The Role of TLRs in Obesity and Its Related Metabolic Disorders.

本文引用的文献

1
Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.Toll 样受体 9 通过诱导小鼠白细胞介素-1β促进脂肪性肝炎。
Gastroenterology. 2010 Jul;139(1):323-34.e7. doi: 10.1053/j.gastro.2010.03.052. Epub 2010 Mar 27.
2
Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults.2 型糖尿病患者的肠道微生物群与非糖尿病患者不同。
PLoS One. 2010 Feb 5;5(2):e9085. doi: 10.1371/journal.pone.0009085.
3
C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.
Toll样受体在肥胖及其相关代谢紊乱中的作用
Int J Mol Sci. 2025 Mar 1;26(5):2229. doi: 10.3390/ijms26052229.
4
Fructose regulates the pentose phosphate pathway and induces an inflammatory and resolution phenotype in Kupffer cells.果糖调节戊糖磷酸途径,并在枯否细胞中诱导炎症和解决表型。
Sci Rep. 2024 Feb 18;14(1):4020. doi: 10.1038/s41598-024-54272-w.
5
Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy.双氢青蒿素通过减轻炎症和氧化应激以及促进自噬来改善代谢相关脂肪性肝病小鼠的肝脂肪变性。
Acta Cir Bras. 2023 Oct 13;38:e385023. doi: 10.1590/acb385023. eCollection 2023.
6
Roles of bacterial extracellular vesicles in systemic diseases.细菌细胞外囊泡在全身性疾病中的作用。
Front Microbiol. 2023 Sep 28;14:1258860. doi: 10.3389/fmicb.2023.1258860. eCollection 2023.
7
Anti-liver fibrosis activity of curcumin/chitosan-coated green silver nanoparticles.姜黄素/壳聚糖包覆绿色银纳米粒子的抗肝纤维化活性。
Sci Rep. 2022 Nov 1;12(1):18403. doi: 10.1038/s41598-022-23276-9.
8
The immune response as a therapeutic target in non-alcoholic fatty liver disease.免疫反应作为非酒精性脂肪性肝病的治疗靶点。
Front Immunol. 2022 Oct 10;13:954869. doi: 10.3389/fimmu.2022.954869. eCollection 2022.
9
The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity.植物化学物质作为对抗肥胖的代谢信号的结构基础
Front Nutr. 2022 Jun 13;9:913883. doi: 10.3389/fnut.2022.913883. eCollection 2022.
10
MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-B Signaling in Mice.MFG-E8 通过促进 TLR4/NF-B 信号通路的激活加剧小鼠非酒精性脂肪性肝炎。
Mediators Inflamm. 2022 Jun 20;2022:5791915. doi: 10.1155/2022/5791915. eCollection 2022.
C-C 趋化因子受体 2 (CCR2) 调节髓样细胞向肝脏的募集,促进肥胖诱导的肝脂肪变性。
Diabetes. 2010 Apr;59(4):916-25. doi: 10.2337/db09-1403. Epub 2010 Jan 26.
4
Clodronate liposomes: all sites of injection are not equal.氯膦酸盐脂质体:并非所有注射部位都是相同的。
Hepatology. 2010 Feb;51(2):721-2; author reply 722. doi: 10.1002/hep.23455.
5
Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.库普弗细胞通过白细胞介素-1β依赖性抑制过氧化物酶体增殖物激活受体α活性促进肝脂肪变性。
Hepatology. 2010 Feb;51(2):511-22. doi: 10.1002/hep.23337.
6
Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease.肿瘤坏死因子-α加速非酒精性脂肪性肝病小鼠模型中脂肪变性肝细胞的凋亡。
Biochem Biophys Res Commun. 2010 Jan 22;391(4):1731-6. doi: 10.1016/j.bbrc.2009.12.144. Epub 2009 Dec 31.
7
Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance.耗竭肝枯否细胞可预防饮食诱导的肝脂肪变性和胰岛素抵抗的发生。
Diabetes. 2010 Feb;59(2):347-57. doi: 10.2337/db09-0016. Epub 2009 Nov 23.
8
Selective inhibition of NF-kappaB in Kupffer cells: good, but not for everything.选择性抑制库普弗细胞中的核因子-κB:有好处,但并非适用于所有情况。
Gut. 2009 Dec;58(12):1581-2. doi: 10.1136/gut.2009.183400.
9
Kupffer cell activation is a causal factor for hepatic insulin resistance.枯否细胞激活是肝胰岛素抵抗的一个因果因素。
Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G107-16. doi: 10.1152/ajpgi.00391.2009. Epub 2009 Oct 29.
10
Tlr2 is critical for diet-induced metabolic syndrome in a murine model.Tlr2 在小鼠模型中对饮食诱导的代谢综合征至关重要。
FASEB J. 2010 Mar;24(3):731-9. doi: 10.1096/fj.09-141929. Epub 2009 Oct 19.